Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Total 13F shares
-
40,249,929
-
Share change
-
+341,076
-
Total reported value
-
$231,250,449
-
Put/Call ratio
-
15%
-
Price per share
-
$5.76
-
Number of holders
-
105
-
Value change
-
-$1,583,181
-
Number of buys
-
51
-
Number of sells
-
48
Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q1 2023
As of 31 Mar 2023,
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,249,929 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, EcoR1 Capital, LLC, COWEN AND COMPANY, LLC, BlackRock Inc., TANG CAPITAL MANAGEMENT LLC, Carlyle Group Inc., VANGUARD GROUP INC, MORGAN STANLEY, and Polar Capital Holdings Plc.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.